Literature DB >> 9482179

Intracerebral inflammation after human brain contusion.

S Holmin1, J Söderlund, P Biberfeld, T Mathiesen.   

Abstract

OBJECTIVE: This study was undertaken to analyze the inflammatory components in contused human brain tissue to compare the findings with previous experimental data regarding the pathogenesis of brain contusions.
METHODS: Contused brain tissue biopsies were obtained from 12 consecutive patients undergoing surgery for brain contusions 3 hours to 5 days after trauma. Inflammatory and immunological components were analyzed by immunohistochemistry.
RESULTS: In patients undergoing surgery less than 24 hours after trauma, the inflammatory response was limited to vascular margination of polymorphonuclear cells. In patients undergoing surgery 3 to 5 days after trauma, however, a massive inflammatory response consisting of monocytes/macrophages, reactive microglia, polymorphonuclear cells, and CD4- and CD8-positive T lymphocytes was detected. Human lymphocyte antigen-DQ was expressed on reactive microglia and infiltrating leukocytes in the late patient group. In addition, CD1a, which is a marker for antigen-presenting dendritic cells, was detected in a subgroup of microglial cells.
CONCLUSION: The results corroborated hypotheses derived from experimental data. In the early phase after contusional trauma, inflammation is mainly intravascular and dominated by polymorphonuclear cells. The inflammation was parenchymal in patients undergoing surgery 3 to 5 days after trauma. The brain swelling seemed to be biphasic, the delayed phase correlating with a parenchymal inflammation. The inflammatory cells may produce several potentially harmful effects, such as acute cellular degeneration; they may also lead to degenerative long-term effects.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9482179     DOI: 10.1097/00006123-199802000-00047

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  68 in total

Review 1.  Expression profiling following traumatic brain injury: a review.

Authors:  Paolo G Marciano; James H Eberwine; Ramesh Ragupathi; Kathryn E Saatman; David F Meaney; Tracy K McIntosh
Journal:  Neurochem Res       Date:  2002-10       Impact factor: 3.996

2.  Blood-brain barrier pathophysiology in traumatic brain injury.

Authors:  Adam Chodobski; Brian J Zink; Joanna Szmydynger-Chodobska
Journal:  Transl Stroke Res       Date:  2011-12       Impact factor: 6.829

Review 3.  Bridge between neuroimmunity and traumatic brain injury.

Authors:  Matthew L Kelso; Howard E Gendelman
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

4.  "Dilated perivascular spaces: a hallmark of mild traumatic brain injury"--a new paradigm?

Authors:  Gregory Chaljub
Journal:  AJNR Am J Neuroradiol       Date:  2005-04       Impact factor: 3.825

5.  Dilated perivascular spaces: hallmarks of mild traumatic brain injury.

Authors:  Matilde Inglese; Elan Bomsztyk; Oded Gonen; Lois J Mannon; Robert I Grossman; Henry Rusinek
Journal:  AJNR Am J Neuroradiol       Date:  2005-04       Impact factor: 3.825

6.  Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord.

Authors:  Kristina A Kigerl; John C Gensel; Daniel P Ankeny; Jessica K Alexander; Dustin J Donnelly; Phillip G Popovich
Journal:  J Neurosci       Date:  2009-10-28       Impact factor: 6.167

7.  Immunological properties of embryonic and adult stem cells.

Authors:  Francesco Bifari; Luciano Pacelli; Mauro Krampera
Journal:  World J Stem Cells       Date:  2010-06-26       Impact factor: 5.326

Review 8.  [Traumatic brain injury: impact on timing and modality of fracture care].

Authors:  P F Stahel; W Ertel; C E Heyde
Journal:  Orthopade       Date:  2005-09       Impact factor: 1.087

9.  Tumor necrosis factor in traumatic brain injury: effects of genetic deletion of p55 or p75 receptor.

Authors:  Luca Longhi; Carlo Perego; Fabrizio Ortolano; Silvia Aresi; Stefano Fumagalli; Elisa R Zanier; Nino Stocchetti; Maria-Grazia De Simoni
Journal:  J Cereb Blood Flow Metab       Date:  2013-04-24       Impact factor: 6.200

10.  S100B inhibition reduces behavioral and pathologic changes in experimental traumatic brain injury.

Authors:  Shruti V Kabadi; Bogdan A Stoica; Danna B Zimmer; Lauriaselle Afanador; Kara B Duffy; David J Loane; Alan I Faden
Journal:  J Cereb Blood Flow Metab       Date:  2015-07-08       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.